Print

Lay Description

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.

Category

  • Cancers and Other Neoplasms
  • Germ Cell Tumors of the CNS
IRB Number
20180694HU
NCT Number
NCT02582697
Open to Enrollment
Yes

Eligibility

Eligible Ages
Between 11 Years and 45 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact


Jaclyn Hung
+1 (210) 450-5358
hungj@uthscsa.edu

Anne-Marie Langevin
(210) 567-7460
langevin@uthscsa.edu

Principal Investigator
Anne-Marie Langevin